Skip to Main Content
Bioimaging Sciences
YSM Home

INFORMATION FOR

Federal Grants

FY 2019 & 2020 Federal Grants

  • Henry Huang, NIH, Novel PET Radiotracer for Muscarinic M1 Receptor, $404,415, 07/09/19 - 06/30/20.
  • Rich Carson, NIH, Penn PET Addiction Center of Excellence (Penn PACE), $1,124,574, 08/15/19 - 06/30/24.
  • Henry Huang, NIH, Penn PET Addiction Center of Excellence (Penn PACE); Yale Radiochemistry Core, $852,229, 08/15/19 - 06/30/24.
  • Dustin Scheinost, NIH, Interpersonal Assignment, $33,956, 09/01/19 - 08/31/20.
  • Graeme Mason, NIH, Interpersonal Assignment, $66,279, 09/01/19 - 08/31/20.
  • Mark Dias, NIH, Interpersonal Assignment, $44,051, 09/01/19 - 08/31/20.
  • Chi Liu and Rich Carson, NIH, Quantitative Low-Dose PET Imaging, $167,376, 09/1/19 - 04/30/20.
  • Rich Carson, NIH, Dose reduction in pediatric/adolescent brain PET Imaging Through Artificial Neural Networks, $34,605, 09/03/19 - 08/31/20.
  • Jean-Dominique Gallezot, NIH, Non-invasive Estimation of the Arterial Input Function in PET Studies Using Whole-Body Physiological Models, $670,000, 09/16/19 – 06/30/22.
  • Rich Carson, NIH, Center without Walls for Imaging Proteinopathies with PET (CW2IP2), $1,183,958, 09/24/19 - 06/30/24.
  • Henry Yaggi, Declan Barry, Nancy Redeker, Dustin Scheinost, NIH, The Collaboration Linking Opioid Use Disorder and Sleep (CLOUDS) Study, $4,672,265, 09/27/19 – 08/31/23.
  • Kathleen Garrison, Dustin Scheinost, and Sarah Yip, NIH, Real-time fMRI Neurofeedback of Large-scale Network Dynamics in Opioid Use Disorder, $460,625, 09/30/19 – 08/31/21.
  • Henry Huang and Chris Van Dyck, NIH, Validation of Fluorine-18 Radioligand for PET Imaging of Synaptic Density in Alzheimer's Disease, $3,863,955, 01/01/20 – 12/31/24.
  • Sarah Yip and Dustin Scheinost, NIH, Connectome-based prediction and neurodevelopmental trajectories of alcohol phenotypes across development, $1,731,879, 06/01/19 - 02/28/23.
  • Jason Bini, NIH, Direct measurement of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme levels in obesity using a novel positron emissiontomography radioligand, $770,730, 07/01/19 - 06/30/24.
  • Todd Constable and Dustin Scheinost, NIH, "An Individualized, Multidimensional Approach to Psychopathology," $4,191,895, 08/01/19 - 05/31/24.
  • Stephanie Noble, NIH, Improving Reliability and Validity of fMRI Statistical Methods, $292,672, 08/01/19 – 09/30/23.
  • Yihuan Lu, NIH, Data-Driven Simultaneous Respiratory and Body Motion Correction for PET/CT, $167,500, 08/15/19 – 05/31/21.
  • Graeme Mason and Rajita Sinha, NIH, Neuroimaging Sciences Training Program, (renewal), $1,853,358 , 07/01/07 – 06/30/24.
  • Jason Cai, NIH, Development of BBB Permeable PD-L1 PET Imaging Agents , $460,625, 08/08/19 – 05/31/21.
  • Evan Morris and Suchitra Krishnan-Sarin, NIH, PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers, $200,000, 07/01/19 – 06/30/20.
  • Chi Liu and Rich Carson, NIH, Quantitative Low-dose PET Imaging, $2,701,318, 07/24/18 - 04/30/22.
  • Chi Liu and Mike Casey, (Siemens), NIH, Personalized Task-based Respiratory Motion Correction for Low-dose PET/CT, $3,220,653, 07/02/18 - 06/30/23.
  • Robin de Graaf and Henk De Feyter, NIH, Deuterium Metabolic Imaging (DMI) of Neurological Disease, $2,696,662, 04/15/19 – 12/31/22.
  • James Duncan, Al Sinusas and Matt O'Donnell, (University of Washington), NIH, q4DE: A Biomarker for Image-guided, Post-MI Hydrogel Therapy, $3,196,757, 04/01/19 - 02/23/23.
  • Gigi Galiana, NIH, Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling, $460,625, 09/11/18 - 08/31/20.
  • Michelle Hampson and Ilan Harpaz-Rotem,NIH, Neurofeedback of Amygdala Activity for PTSD, $1,154,287, 09/01/18 - 07/31/20.
  • Ansel Hillmer, NIH, Imaging the Opioid Response to Cannabis Smoking, $251,250, 02/01/19 - 01/31/20.
  • Henry Huang, NIH, PET Radiotracers to Image the Enzyme 11beta-hydroxysteroid Dehydrogenase-1 (11beta-HSD1), $1,631,066 07/05/18 - 05/30/20.
  • Evan Morris, NIH, Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse? $5,396,413, 08/01/18 - 05/31/23.
  • Stephanie Noble, NIH, Improving Reliability and Validity of fMRI Statistical Methods, $45,524, 09/01/18 - 08/31/23.
  • Dana Peters, NIH, Development of MR-derived Parameters of LV Diastolic Function: Validation Comparison to LV and LA Fibrosis, $1,830,429, 01/01/19 - 12/31/22.
  • Doug Rothman and Janice Huang, NIH, Glucoregulatory Hormone Interactions in Diabetes, (Transfer of Sherwin Grant), $3,300,249, 01/01/19 - 07/31/23.
  • Hemant Tagare, NIH, DaTscan-based Disease Progression Models for Early-stage Parkinson's Disease, $1,405,183, 07/01/18- 04/30/22.